Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona Registry
2017 · Clinical Rheumatology · 14 citations
https://doi.org/10.1007/s10067-017-3742-2
S
Steve Zlotnick
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
825
Citations
9
h-index
9
i10-index
Steve Zlotnick is an academic researcher. The author has contributed to research in topics: Rheumatoid Arthritis Research and Therapies & Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment. The author has an h-index of 9, co-authored 22 publications.
Papers by this author
worksReal-world Comparative Effectiveness of Tocilizumab Monotherapy vs. Tumor Necrosis Factor Inhibitors with Methotrexate in Patients with Rheumatoid Arthritis
2018 · Rheumatology and Therapy · 12 citations
https://doi.org/10.1007/s40744-018-0127-1
Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
2020 · Rheumatology and Therapy · 8 citations
https://doi.org/10.1007/s40744-020-00200-z
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
2019 · Rheumatology and Therapy · 4 citations
https://doi.org/10.1007/s40744-019-0162-6
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry
2021 · Rheumatology and Therapy · 1 citations
https://doi.org/10.1007/s40744-021-00285-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat